Revati Shreeniwas

Revati Shreeniwas

Presidente en
Revati, Inc.
.
65 años
Health Technology
Consumer Services
Commercial Services

Perfil

Currently, Revati Shreeniwas is President at Revati, Inc. since 2004 and a Member at Continuing Medical Education, Inc. Formerly, Dr. Shreeniwas was Chief Medical Officer at Bright Minds Biosciences, Inc. from 2020 to 2022, Chief Medical Officer at NeurAxon Pharma, Inc. from 2015 to 2017, Vice President-Clinical Development at Soleno Therapeutics, Inc. from 2019 to 2020, Vice President-Clinical Research & Development at Alvine Pharmaceuticals, Inc., Principal at Scios, Inc., Principal at CV Therapeutics, Inc., Principal at The Trustees of Columbia University in The City of New York, Professor at Stanford University.

Cargos activos de Revati Shreeniwas

EmpresasCargoInicio
Corporate Officer/Principal -
Revati, Inc.
Presidente 01/01/2004

Antiguos cargos conocidos de Revati Shreeniwas.

EmpresasCargoFin
BRIGHT MINDS BIOSCIENCES INC. Director Técnico/Científico/I+D 01/12/2022
SOLENO THERAPEUTICS, INC. Director Técnico/Científico/I+D 01/06/2020
Director Técnico/Científico/I+D 01/01/2017
Corporate Officer/Principal -
Corporate Officer/Principal -
Ver el detalle de la experiencia de Revati Shreeniwas.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

4

Relaciones de 1er grado

10

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas10

Health Technology

Health Technology

Revati, Inc.

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

  1. Bolsa de valores
  2. Insiders
  3. Revati Shreeniwas